NeoSun - Final Version 2.0

• Research type

  Research Study

• Full title

  A Phase II Study of Neoadjuvant Sunitinib in Metastatic Renal Cell Carcinoma

• IRAS ID

  10880

• Sponsor organisation

  Cambridge University Hospitals NHS Foundation Trust

• Eudract number

  2005-004502-82

• ISRCTN Number

  Applying

• Research summary

  N/A

• REC name

  East of England - Cambridge East Research Ethics Committee

• REC reference

  09/H0304/69

• Date of REC Opinion

  11 Nov 2009

• REC opinion

  Further Information Favourable Opinion